10 August 2017 15:50
(ShareCast News) - Homebuilders' shares were at the bottom of the pile as evidence appeared to mount that recent stamp duty changes were indeed dampening activity in the sector.
1 August 2017 07:49
(ShareCast News) - FTSE 100 housebuilder Taylor Wimpey reported a 24% drop in first-half pre-tax profit on Tuesday as it put aside £130m for homebuyers that were affected by a leasehold scandal.
25 July 2017 07:59
(ShareCast News) - The UK government on Tuesday said it would ban builders from selling new homes as leasehold and was considering cutting ground rents to zero to curb a growing national scandal that has...
13 July 2017 09:35
(ShareCast News) - National Grid: HSBC upgrades to Buy with a target price of 1060p.
9 June 2017 08:06
(ShareCast News) - London-listed housebuilders slumped on Friday as investors woke up to news of a hung parliament, after PM Theresa May failed to get the seats needed to deliver a majority government.
28 April 2017 09:00
(ShareCast News) - Drax: Barclays upgrades to Overweight with a target price of 410p.
27 April 2017 07:25
(ShareCast News) - Housebuilder Taylor Wimpey has set aside £130m to cover claims from customers over leasehold policies that have doubled ground rents for home owners.
21 April 2017 15:49
(ShareCast News) - Gains at the end of the week were being driven by a mix of defensive and more cyclical issues, driven in part by analysts' comments on different segments of the markets and ahead of...
13 April 2017 16:54
(ShareCast News) - Equities in London ended Thursday mixed, ahead of the Easter weekend, as investors headed for safe-haven assets after US President Donald Trump said the dollar was over valued.
12 April 2017 16:49
(ShareCast News) - Equities trade in London became duller as the day progressed with a blend of geopolitical tensions and the upcoming long Easter weekend suppressing interest.
10 April 2017 08:30
(ShareCast News) - AstraZeneca: Jefferies downgrades to Hold with a target price of 5050p.
24 March 2017 16:26
(ShareCast News) - Equities in London spent most of the session adrift with a slightly negative bias ahead of the US congressional vote on President Donald Trump's Healthcare Bill, with little in the...
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2017. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.